Today: 7 February 2026
Subscribe
Browse Category

Investment Insights News 28 December 2025 - 31 December 2025

CoreWeave stock slides in year-end trade after insider sale filing puts CRWV back in focus

CoreWeave stock slides in year-end trade after insider sale filing puts CRWV back in focus

NEW YORK, December 31, 2025, 12:57 ET — Regular session CoreWeave (CRWV) shares fell 2.0% to $72.40 by 12:57 p.m. ET, after trading between $72.04 and $74.30 in the session. The move matters because CoreWeave remains a high-volatility play on artificial intelligence infrastructure, where investors have been quick to react to signals about insider selling and capital needs. SEC+1 Year-end positioning is adding another layer, with investors looking to lock in tax losses and rebalance portfolios in a market that can turn jumpy on thin liquidity. Business Insider A Form 4 filed with the U.S. Securities and Exchange Commission showed
31 December 2025
···
Apple stock slips in year-end trading as tech drags; what investors watch next

Apple stock slips in year-end trading as tech drags; what investors watch next

NEW YORK, December 31, 2025, 12:07 ET — Regular session Apple shares dipped on Wednesday as investors continued to trim exposure to large technology names into the end of the year. The iPhone maker’s stock was down 0.2% at $272.63, after trading between $271.78 and $273.58. The move mattered because Apple’s enormous weighting in major indexes often makes it a bellwether for shifts in risk appetite on quiet days, when small flows can move prices more than usual. U.S. stocks were modestly lower in holiday-thin trading, extending a late-December drift that has undercut expectations for a “Santa Claus rally,” a
31 December 2025
·······
D-Wave Quantum stock pops today as QBTS outperforms on year-end options buzz

D-Wave Quantum stock pops today as QBTS outperforms on year-end options buzz

NEW YORK, December 30, 2025, 1:03 PM ET — Regular session D-Wave Quantum Inc. shares climbed on Tuesday, extending a choppy year-end stretch for quantum-computing stocks as the group again outperformed a flat-to-weaker U.S. market. Reuters The move matters because quantum names have become a high-beta pocket of the tech market, with swings amplified by thin holiday liquidity and active retail trading. Investors.com said the group saw a late-December pop followed by profit-taking in the sessions that followed. Investors.com D-Wave has been one of the sector’s standout gainers in 2025, but the stock remains well off its highs, underscoring how
30 December 2025
·····
NIO stock jumps 4.7% after CEO sets Q4 sales bar — what to watch next

NIO stock jumps 4.7% after CEO sets Q4 sales bar — what to watch next

NEW YORK, December 30, 2025, 02:27 ET — Market closed NIO Inc (NIO.N) shares rose 4.71% to $5.34 on Monday, extending a three-session rise even as U.S. stocks slipped. CEO William Li said fourth-quarter vehicle sales “should exceed 30 billion yuan” at a customer event in China, TipRanks reported. Volume climbed to 68.3 million shares and the stock remains about 33% below its 52-week high of $8.02; TipRanks noted Tesla and Li Auto fell on the day. The read-through for investors is whether Nio can finish the year with momentum while China’s EV makers fight for market share and pricing
30 December 2025
····
Praxis Precision Medicines (PRAX) stock jumps 13% after FDA breakthrough designation for tremor drug

Praxis Precision Medicines (PRAX) stock jumps 13% after FDA breakthrough designation for tremor drug

NEW YORK, December 30, 2025, 00:52 ET — Market closed. Praxis Precision Medicines shares climbed about 13% in Monday’s session, last trading at $304.58, after the company said U.S. regulators granted Breakthrough Therapy Designation for its experimental essential tremor treatment. The stock swung between $318.08 and $275.00 during the day. The designation, known as BTD, is an FDA pathway meant to speed development and review of drugs for serious conditions when early clinical evidence suggests a meaningful improvement over available options. U.S. Food and Drug Administration Praxis said the BTD was granted for ulixacaltamide and that it expects to submit
30 December 2025
·····
Hindalco sets Feb 12 results meeting as stock nears fresh highs; Novelis outlook in focus

Hindalco sets Feb 12 results meeting as stock nears fresh highs; Novelis outlook in focus

NEW YORK, December 30, 2025, 00:19 ET Hindalco Industries said its board will meet on Feb. 12 to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended Dec. 31, 2025. Rediff The timing gives investors a clear date for the next earnings update as the stock trades near record levels and attention stays on its U.S. subsidiary Novelis and the ramp-up of its Bay Minette project. Hindalco shares were up 1.16% at 875.50 rupees by 10:30 a.m. IST on Tuesday, data showed. Business StandardThe stock touched a new 52-week high of 887.45 rupees
30 December 2025
····
Costco stock slips after hours as year-end trading thins and January sales update looms

Costco stock slips after hours as year-end trading thins and January sales update looms

NEW YORK, December 29, 2025, 17:45 ET — After-hours Costco Wholesale shares fell 0.6% in after-hours trading on Monday to $867.84. The dip comes as investors head into the final two trading sessions of 2025 with holiday liquidity thin and little company-specific news to reset near-term expectations. Reuters Costco’s stock has become a high-profile gauge for how well big-box retailers can hold demand without heavy discounting, helped by its membership-fee model. Those fees are a key profit driver because they carry much higher margins than most of the goods sold in warehouses. Nasdaq+1 U.S. stocks closed lower on Monday, with
30 December 2025
·····
Boeing stock edges up after report flags 737 MAX production push for 2026

Boeing stock edges up after report flags 737 MAX production push for 2026

NEW YORK, December 29, 2025, 13:19 ET — Regular session Boeing shares edged up on Monday after an industry publication reported the planemaker is preparing to increase monthly 737 MAX production to 47 aircraft by early summer 2026. The stock was up 0.4% at $217.34 in early afternoon trading. ch-aviation The reported production push matters because Boeing’s delivery pace drives cash generation and backlog burn-down, and any move above current rates typically needs regulatory clearance and supplier capacity. The 737 MAX is Boeing’s highest-volume jet program and a focal point for investors tracking the company’s recovery. ch-aviation Boeing has been
29 December 2025
·····
AMD slips as tech rally pauses; Nvidia-Intel filing puts chip sector back in focus

AMD slips as tech rally pauses; Nvidia-Intel filing puts chip sector back in focus

NEW YORK, December 29, 2025, 09:54 ET — Regular session Advanced Micro Devices shares edged lower in early trading on Monday, dipping 0.3% to $214.42 after touching an intraday low of $209.42. The move mattered because the market is entering the final, holiday-thinned stretch of the year, when small shifts in risk appetite can swing high-growth technology names. Semiconductor stocks have been at the center of the AI-driven rally and remain sensitive to any change in rates and spending expectations. Reuters+1 AMD is one of the sector’s key bellwethers, sitting between Nvidia in AI accelerators and Intel in server processors.
29 December 2025
········
Bristol Myers stock drifts near $55 as year-end trading thins and Fed minutes loom

Bristol Myers stock drifts near $55 as year-end trading thins and Fed minutes loom

NEW YORK, December 28, 2025, 23:31 ET — Market closed Bristol Myers Squibb shares ended Friday slightly lower at $54.64, as the U.S. market headed into the year’s final trading days with few fresh company-specific catalysts. Bristol Myers Squibb That matters now because thin year-end liquidity — lower trading volume around the holidays — can amplify day-to-day swings, even when headlines are scarce. Investors are also adjusting portfolios into 2026, a process that can trigger abrupt sector rotations. Reuters For Bristol Myers, a large-cap drugmaker often traded as a defensive holding, the near-term tape is being shaped more by rates
29 December 2025
·····
Boeing stock in focus before Monday after E-7 cost report, new airline buy plans

Boeing stock in focus before Monday after E-7 cost report, new airline buy plans

NEW YORK, December 28, 2025, 22:14 ET — Market closed Boeing shares will head into Monday’s session with fresh attention on its defense programs after the Wall Street Journal reported Congress stepped in to keep funding for the U.S. Air Force’s E-7 Wedgetail radar jet effort. Wall Street Journal The planemaker’s stock last closed down 0.8% at $216.44 on Friday. The development matters because Boeing’s defense portfolio can swing quarterly results when programs run over budget, even as investors stay focused on the company’s broader push to increase commercial jet deliveries and improve cash generation. Boeing traded between $216.11 and
29 December 2025
····
BigBear.ai Stock (NYSE: BBAI) Weekend Update: Share-Authorization Vote Deadline Looms as Short Interest Stays Elevated

BigBear.ai Stock (NYSE: BBAI) Weekend Update: Share-Authorization Vote Deadline Looms as Short Interest Stays Elevated

NEW YORK, Dec. 28, 2025, 5:15 PM ET — U.S. stock market closed (Weekend). BigBear.ai Holdings, Inc. (NYSE: BBAI) heads into Monday’s session with investors balancing two competing narratives: unusually active trading interest in smaller AI names and a high-volatility setup fueled by elevated short positioning—while a time-sensitive shareholder vote on expanding authorized shares remains in focus. With U.S. exchanges closed for the weekend, the most actionable “catalyst clock” for BBAI is not a macro data print—it’s the company’s reconvened special meeting and the final hours to submit electronic votes. BigBear.ai Holdings, Inc.+1 Where BBAI left off: last session’s drop,
28 December 2025
···
1 … 16 17 18 19 20 … 67

Stock Market Today

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

7 February 2026
Walmart shares rose 3.3% Friday to $131.18, up 10% since Jan. 30, as the Dow closed above 50,000 for the first time. The retailer’s market value crossed $1 trillion this week. Investors await January inflation data on Feb. 13 and Walmart’s quarterly results on Feb. 19 for signs of continued momentum.
Go toTop